Long ‐Term Analysis of Phase II Studies of Single‐Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - July 11, 2017 Category: Hematology Authors: Thomas E. Witzig, Pier Luigi Zinzani, Thomas M. Habermann, Joseph M. Tuscano, Johannes Drach, Radhakrishnan Ramchandren, Sevgi Kalayoglu Besisik, Kenichi Takeshita, Marie ‐Laure Casadebaig Bravo, Lei Zhang, Tommy Fu, Andre Goy Tags: Research Article Source Type: research